DHX Company Co., Ltd. (KOSDAQ:031860)

South Korea flag South Korea · Delayed Price · Currency is KRW
475.00
+109.00 (29.78%)
At close: Mar 9, 2026
-49.25%
Market Cap 9.02B
Revenue (ttm) 16.38B
Net Income (ttm) -22.28B
Shares Out 18.98M
EPS (ttm) -1,305.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,707,834
Average Volume 497,124
Open 465.00
Previous Close 366.00
Day's Range 451.00 - 475.00
52-Week Range 202.00 - 1,783.00
Beta 0.12
RSI 52.03
Earnings Date Mar 20, 2026

About DHX Company

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset ma... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1979
Employees 23
Stock Exchange KOSDAQ
Ticker Symbol 031860
Full Company Profile

Financial Performance

In 2024, DHX Company's revenue was 9.54 billion, a decrease of -14.28% compared to the previous year's 11.13 billion. Losses were -17.59 billion, -44.57% less than in 2023.

Financial Statements

News

There is no news available yet.